Humacyte, Inc. (HUMA): debt financing — Humacyte (HUMA) amends revenue interest purchase agreement; $50M repayment, discounted call option

Humacyte, Inc.

Company to make $50.0M repayment under Purchase Agreement from restricted cash.
Obligation to maintain $50.0M restricted cash removed; if not repaid by Dec 31, 2025, $12.5M required.
Call option at discounted repurchase price of $95.5M if exercised on or before Dec 31, 2025; up to $7.5M may be paid in stock.
Amendment executed with TPC Investments III LP and TPC Investment Solutions LP, agented by Hook SA LLC.

item 1.01 item 2.03 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Humacyte, Inc. amended debt with TPC Investments III LP and TPC Investment Solutions LP.

Counterparty: TPC Investments III LP and TPC Investment Solutions LP
Event: amendment

Exact text from the filing

ith TPC Investments III LP and TPC Investment Solutions LP (collectively, the “Purchasers”) and Hook SA LLC, as agent for

View on SEC.gov

10 debt financings filed in the last 30 days. Browse all debt financings →

Humacyte, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-25-090963

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.